TrialBritish journal of cancer2008
Phase II trial of imatinib mesylate in patients with metastatic melanoma.
K B Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
73 papers cite itlatest 60 shown
this paperpooled ittrialcites it